Winthrop Pharmaceuticals UK Ltd

One Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 554 831
E-mail: UK-medicalinformation@sanofi-aventis.com
Medical Information Direct Line: +44 (0)1483 554 101
Medical Information Fax: +44 (0)1483 554 831

Patient Information Leaflet last updated on the eMC: 29/03/2011
PIL MigraMax

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change of licence holder
Updated on 06/03/2009 and displayed until 29/03/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/01/2009 and displayed until 06/03/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change of inactive ingredient
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 03/06/2008 and displayed until 16/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 01/08/2001 and displayed until 03/06/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   lysine acetylsalicylate
   metoclopramide hydrochloride